Clinical trials
Phase 3 Substance-Related Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 5 |
| Chestnut Health Systems | 4 |
| Johns Hopkins University | 4 |
| Butler Hospital | 3 |
| Dartmouth-Hitchcock Medical Center | 3 |
| Norwegian University of Science and Technology | 3 |
| Boston Medical Center | 2 |
| Brigham and Women's Hospital | 2 |
| University of California, Los Angeles | 2 |
| University of Cincinnati | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Substance-Related Disorders | 62 |
| Opioid-Related Disorders | 13 |
| Alcoholism | 7 |
| HIV Infections | 6 |
| Cocaine-Related Disorders | 3 |
| Mental Disorders | 3 |
| Stress Disorders, Post-Traumatic | 3 |
| Anxiety Disorders | 2 |
| Bipolar Disorder | 2 |
| Chemically-Induced Disorders | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.